Neurology Week July 14-18, 2021

Congratulations to Drs. Vontell and Tolea on Being Selected for the NIA- 1FL ADRC AlzSTARS Scholarship

Congratulations to Drs. Regina Vontell and Magda Tolea who got selected for NIA- 1FL ADRC AlzSTARS (Alzheimer’s Science Training to Advance Research Success) scholarship.

Join us for a fantastic talk in Spanish, given by Dr. Michelle Marrero. El rol vital de la nutrición en el cerebro

5 Things to Know About the Alzheimer’s Drug Aducanumab

The FDA approves Aduhelm (aducanumab) to treat patients with Alzheimer’s disease

FDA approves Aduhelm (aducanumab) using the accelerated approval pathway used for drugs treating serious or life-threatening illness that provide a meaningful therapeutic advantage over existing treatments. The drug is shown to have an effect and reasonably likely to have a clinical benefit to patients, yet there remains some uncertainty about the drug’s true clinical benefit.

https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease

https://www.nia.nih.gov/news/nia-statement-fda-approval-aducanumab-alzheimers-disease

The Spring 2021 edition of University of Miami Medicine magazine is now online. The lead story, Healthy Aging, describes Miller School of Medicine researchers’ groundbreaking findings related to Alzheimer’s disease and other forms of dementia.

NIA study identifies FDA-approved drugs that may also be helpful for dementia

Providing the Right Diagnosis for Lewy Body Dementia Patients